BioWorld Asia

April 9, 2003

Serono Signs On Graffinity As Partner For Drug Development

Graffinity AG, a specialist in preclinical drug discovery, landed a commitment from Serono SA to help fill the development pipeline of Europe's largest biotechnology company. (BioWorld International) Read More

Epigenomics Raises EUR21M To Fund Work In DNA Methylation

Angiogenesis Study Encourages Prospects In Ischemia Treatment

GeneProt Slashes Staff, Cites Current Economic Environment

Ester Neuroscience Gets Good Results In Early Antisense Trial

Chiasma Gets First Biotech Investment From InnoMed

Galapagos Enters Collaboration In Nutraceuticals With Degussa

European Officials Craft Report On Embryonic Stem Cell Research

SR Pharma Taking Stock After Acquiring Rodaris, Joint Venture

EBML Targets Young Companies In Europe With New EUR25M Fund

Bioline Therapeutics Formed By Israeli Groups With $11M Funding

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 17, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 17, 2025.

Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA

BioWorld

During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...

23andme founder-led group outbids Regeneron for company

BioWorld

The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...

Elevidys’ second liver death hits Sarepta, sends DMD ripples

BioWorld

How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...